Malignant Rhabdoid Tumor
📧 Sign up to get email alerts when something new happens for Malignant Rhabdoid Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: Phase 2 Study of Alisertib Therapy for Rhabdoid Tumors [Phase 2]
An update on a Phase 2 trial of alisertib for malignant rhabdoid tumors and atypical teratoid rhabdoid tumors, with the study currently acti…
-
CLINICAL_TRIALS trial_result · 2026-03-06Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Solid Tumors [Phase 1]
Phase 1 trial evaluating IL-15 armored glypican-3–specific CAR-T cells for solid tumors, including hepatocellular carcinoma and several pedi…
-
CLINICAL_TRIALS trial_result · 2026-01-21Clinical Trial Update: Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors [Phase 1]
This is an update on a Phase 1 trial of interleukin-15 armored GPC3-specific CAR-T cells for pediatric solid tumors, with results posted and…
-
CLINICAL_TRIALS trial_result · 2025-03-11Clinical Trial Update: A Study of Tazemetostat in Adult Participants With Soft Tissue Sarcoma [Phase 2]
Phase 2 study of tazemetostat in adult participants with soft tissue sarcoma, including rhabdoid tumors, has completed and results were post…
-
CLINICAL_TRIALS trial_result · 2025-02-24Clinical Trial Update: A Study of Panobinostat in Pediatric Patients With Solid Tumors Including MRT/ATRT [Phase 2]
This is a Phase 2 clinical trial update for panobinostat in pediatric solid tumors including malignant rhabdoid tumor and atypical teratoid/…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.